The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

BioNTech has announced that it will be expanding its messenger RNA (mRNA) capabilities by acquiring CureVac for approximately ...

The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.

Several states have effectively declared war on medical progress. Lawmakers in Iowa, Idaho, Texas, and Kentucky have introduced bills that would ban or restrict vaccines that use messenger RNA, or ...

Thermo Fisher Scientific (NYSE:TMO), a key player in the life sciences sector, has taken significant strategic steps amid ...

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...

The shot is approved for the prevention of RSV-associated lower respiratory tract disease in adults aged 60 or older. Read more at straitstimes.com. Read more at straitstimes.com.

Days after Health and Human Services Secretary Robert F. Kennedy Jr. purged the Centers for Disease Control and Prevention’s ...

Novavax's COVID-19-influenza vaccines show strong immune response in older adults, paving the way for regulatory approval.

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...